ALB zeros in on three promising gold targets at Yandal West
Albion Resources has found three new gold target areas to prioritise in maiden drilling set to begin at the Yandal West project next month.
Stockhead
UVA snaps up NZ gold
Uvre locks in binding agreement to acquire Minerals Exploration and its subsidiary, Otagold, in New Zealand, with ASX mining legend Norm Seckold emerging as a major shareholder.
KNB hits broad gold interval at Sunnyside
Koonenberry Gold’s fourth diamond hole at Sunnyside returns 149.5m intersection grading 0.94g/t gold, its third best result to date.
Can this biotech emerge from Mesoblast’s shadow?
Investors now have three ASX-listed stem cell therapy companies to choose from – and we can thank sector big daddy Mesoblast for inspiring the third.
More Stories
ASX March winners and losers
The S&P/ASX 200 fell 3.39% in March 2025 as geopolitical impacts and impending US tariffs played on global markets.
ASX dips as US economy contracts 0.3pc
The ASX has had a wobbly start to trading, dipping marginally in the first hour as US GDP falls 0.3pc, undermined by a spike in imports.
ASX health stocks deliver March quarter progress
Some of the ASX’s most exciting health small caps rolled out their quarterly results this week, including Control Bionics, LTR Pharma, Lumos Diagnostics and EMvision Medical Devices.
ASX quarterly tech wrap
Decidr AI Industries and Adisyn are among ASX technology companies reporting March quarterly results this week.
All you need to know before the ASX opens
Here’s everything you need to know before the ASX opens today.
Top 10 at 11: Fresh from the ASX today
Stockhead’s Top 10 at 11, a short, sharp update to help frame the trading day.
ASX health stocks give March quarter progress
Island Pharmaeuticals, Dimerix and Tryptamine Therapeutics are among ASX health stocks reporting quarterly results this week.
Dimerix inks lucrative US licensing deal
Dimerix has entered an exclusive licensing deal with Amicus Therapeutics to commercialise its phase III drug candidate DMX-200 in the US.
Everything you need to know before the ASX opens
Good morning! Here’s everything you need to know, and some things you don’t, before the ASX flings open its doors and begins trading today.
Tech lifts, Andromeda surges on alumina win
ASX continues winning streak, Tesla quietly preps for life after Elon, and Andromeda hits ultra-pure alumina breakthrough.
Original URL: https://www.goldcoastbulletin.com.au/business/stockhead/page/46